Sivik Global Healthcare LLC
Sector Allocation
- Healthcare74.3%$130.1M
- Other16.2%$28.4M
- Consumer Staples9.4%$16.5M
AUM History
13fpro.ai/research/fund/sivik-global-healthcare-llc-1596452
Conviction and streaks
Stable · top 10 = 46.2%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q3 2026
- SPDR$28.4M
HUM
$6.8MJNJ
$6.4MMRK
$5.8MABBV
$5.8MTMO
$5.7MCAH
$5.6MMCK
$5.5MDHR
$5.5MUNH
$5.5MVRTX
$5.5MELV
$5.4MABT
$5.4MCOR
$5.4MA
$5.2MCNC
$5.0MLLY
$4.9MEHC
$4.9MRVTY
$4.6MWAT
$4.4M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/sivik-global-healthcare-llc-1596452
Sivik Global Healthcare LLC 13F holdings — Q3 2026
$175.0M portfolio (+32.9% QoQ) · 35 holdings · Q3 2026 13F · top 10 are 46% of the stock portfolio
- 1
SPDR SERIES TRUST - ST STR SP BIOT
$28.4M
16.2% of stocks
+20%This quarter—Since filed—HeldAIQuality—Est. buy— $6.8M
3.9% of stocks
-12%This quarter-0.8%Since filed1+ qtrsHeld$6.4M
3.6% of stocks
+20%This quarter+7.1%Since filed1+ qtrsHeld$5.8M
3.3% of stocks
No changeThis quarter-1.0%Since filed1+ qtrsHeld$5.8M
3.3% of stocks
+47%This quarter+4.5%Since filed1+ qtrsHeld$5.7M
3.3% of stocks
+6%This quarter+3.3%Since filed1+ qtrsHeld$5.6M
3.2% of stocks
+4%This quarter+4.9%Since filed1+ qtrsHeld$5.5M
3.2% of stocks
+63%This quarter+3.2%Since filed1+ qtrsHeld$5.5M
3.2% of stocks
+25%This quarter+4.5%Since filed1+ qtrsHeld$5.5M
3.1% of stocks
+50%This quarter+8.7%Since filed1+ qtrsHeld
All holdings — Sivik Global Healthcare LLC (Q3 2026)
35 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | VERTEX PHARMACEUTICALS INC / MA | Healthcare | $5.5M | 3.1% | 11K | +5% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | Elevance Health, Inc. | Healthcare | $5.4M | 3.1% | 14K | +180% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | ABBOTT LABORATORIES | Healthcare | $5.4M | 3.1% | 55K | +120% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | Cencora, Inc. | Consumer Staples | $5.4M | 3.1% | 18K | +20% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | AGILENT TECHNOLOGIES, INC. | Healthcare | $5.2M | 3.0% | 30K | — | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | CENTENE CORP | Healthcare | $5.0M | 2.8% | 80K | New | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | ELI LILLY & Co | Healthcare | $4.9M | 2.8% | 4,230 | -15% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | Encompass Health Corp | Healthcare | $4.9M | 2.8% | 40K | +167% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | REVVITY, INC. | Healthcare | $4.6M | 2.6% | 30K | New | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | WATERS CORP /DE/ | Healthcare | $4.4M | 2.5% | 10K | -33% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | BRUKER CORP | Healthcare | $4.2M | 2.4% | 65K | New | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | Edwards Lifesciences Corp | Healthcare | $3.9M | 2.2% | 45K | +125% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | Medtronic plc | Healthcare | $3.9M | 2.2% | 45K | New | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | REPLIGEN CORP | Healthcare | $3.8M | 2.2% | 20K | New | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | METTLER TOLEDO INTERNATIONAL INC/ | Healthcare | $3.8M | 2.2% | 2,500 | -9% | 1+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $GILD | GILEAD SCIENCES, INC. | Healthcare | $3.7M | 2.1% | 25K | — | |||
| 27 | $CI | Cigna Group | Healthcare | $3.6M | 2.0% | 13K | New | |||
| 28 | $BIIB | BIOGEN INC. | Healthcare | $3.4M | 1.9% | 15K | — | |||
| 29 | $BIO | BIO-RAD LABORATORIES, INC. | Healthcare | $3.0M | 1.7% | 8,000 | -20% | |||
| 30 | $AVTR | Avantor, Inc. | Healthcare | $2.6M | 1.5% | 175K | New | |||
| 31 | $BNTX | BioNTech SE | Healthcare | $2.2M | 1.2% | 22K | New | |||
| 32 | $MRNA | Moderna, Inc. | Healthcare | $1.9M | 1.1% | 10K | New | |||
| 33 | $ARGX | ARGENX SE | Healthcare | $1.9M | 1.1% | 2,000 | New | |||
| 34 | $MDGL | MADRIGAL PHARMACEUTICALS, INC. | Healthcare | $1.3M | 0.7% | 2,500 | New | |||
| 35 | $TWST | Twist Bioscience Corp | Healthcare | $218K | 0.1% | 1,128 | New |
What changed in Q3 2026
Against the previous quarter's 13F: 12 new, 14 added to, 5 trimmed, 11 sold out. Share-count changes; largest moves by dollar size first.
New positions (12)
$CNCCENTENE CORP$5.0M
first bought this quarter
$RVTYREVVITY, INC.$4.6M
first bought this quarter
$BRKRBRUKER CORP$4.2M
first bought this quarter
$MDTMedtronic plc$3.9M
first bought this quarter
$RGENREPLIGEN CORP$3.8M
first bought this quarter
$CICigna Group$3.6M
first bought this quarter
+6 more in the Excel export
Added to (14)
- SPDR SERIES TRUST - ST STR SP BIOT+20%
now $28.4M
$ELVElevance Health, Inc.+180%
now $5.4M · held 1+ qtrs
$EHCEncompass Health Corp+167%
now $4.9M · held 1+ qtrs
$ABTABBOTT LABORATORIES+120%
now $5.4M · held 1+ qtrs
$EWEdwards Lifesciences Corp+125%
now $3.9M · held 1+ qtrs
$MCKMCKESSON CORP+63%
now $5.5M · held 1+ qtrs
+8 more in the Excel export
Trimmed (5)
Holdings by quarter
Every 13F Sivik Global Healthcare LLC has filed, 42 earlier quarters. Pick one to see what it held then.
Is it too late to follow Sivik Global Healthcare?
Q3 2026 13F filed with the SEC on Oct 13, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Sivik Global Healthcare's top 20 holdings: 65/100 (our AI quality score, weighted by position size; 20 of the 20 are scored)
Top 10 since filing
+4.0%
Value-weighted move of the 10 largest stock positions
Turnover
—
Last quarter
Top 10 weight
46%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
0%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q3 2026 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Sivik Global Healthcare LLC disclosed 35 positions worth $175.0M in its Form 13F-HR for Q3 2026, followed by $HUM and $JNJ. During the quarter the fund opened 12 new positions and exited 11 — including a new stake in $CNC. The portfolio is most concentrated in Healthcare (74.3% of disclosed assets). All figures are sourced directly from Sivik Global Healthcare LLC’s Form 13F-HR filing with the SEC under CIK 1596452.
Funds like this
managers whose biggest positions overlap Sivik Global Healthcare'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Sivik Global Healthcare LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Sivik Global Healthcare LLC (SEC CIK: 1596452), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Sivik Global Healthcare LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.